Protein Hydrolysis Enzymes Industry Will Hit Big Revenues In Future
Protein hydrolysis enzymes are enzymes that break down proteins into smaller peptides or amino acids through hydrolysis. This process is essential in various industries, including food and beverage, pharmaceuticals, and cosmetics. The market for protein hydrolysis enzymes is influenced by factors such as increasing demand for protein-based products, advancements in biotechnology, and the growing awareness of the health benefits of protein hydrolysates.
The protein hydrolysis enzymes market size is predicted to grow at a 6.2% CAGR from 2022 to 2027, from USD 2.2 billion in 2022 to USD 2.9 billion in 2027.
Driving factors that are influencing the market:
Growing Demand for Protein Hydrolysates:
- There is an increasing consumer demand for protein-enriched products, especially in the food and beverage industry. Protein hydrolysates offer benefits like improved digestibility and bioavailability of proteins, making them popular in various applications.
Health and Wellness Trends:
- The rising awareness of health and wellness has led to a higher demand for nutritional products with enhanced protein content. Protein hydrolysates are often preferred due to their potential health benefits, including easier absorption and utilization by the body.
Expanding Food and Beverage Industry:
- The food and beverage industry's growth, driven by changing consumer preferences and lifestyles, has positively impacted the protein hydrolysis enzymes market. Enzymes are essential in processes such as the production of protein hydrolysates for use in food and beverage products.
Advancements in Biotechnology:
- Ongoing advancements in biotechnology have contributed to the development of more efficient and specific protein hydrolysis enzymes. This has led to improved processes and products, attracting interest from various industries.
Top players analyzed in the protein hydrolysis enzymes market:
The key players in this market include Novozymes (Denmark), Associated British Foods (UK), DSM (Netherlands), DuPont (US), BASF (Germany), Advanced Enzymes Technologies (India), Dyadic International (US), and Chr. Hansen (Denmark) among others.
Pharmaceuticals segment is identified to be the fastest growing segment among the various application of protein hydrolysis enzymes during the forecast period
Protein hydrolysis enzymes are used extensively for the preparation of medicines, such as ointments for debridement of wounds and used in denture cleaners. Protein hydrolysis enzymes from microbial sources are preferred over those from plant and animal sources due to their wide biochemical diversity and genetic susceptibility. Application of microbial protein hydrolysis enzymes in the pharmaceuticals industry such as serrapeptase, serrazime, lysostaphin, L-asparaginase, L-glutaminase, streptokinase, streptokinase-streptodornase, and xiaflex. These enzymes are used to treat cancer, cardiovascular disease, respiratory tract disorders, and inflammation. Application of plant protein hydrolysis enzymes in the pharmaceutical industry includes papain and bromelain. Papain is an effective enzyme used in treating dyspepsia and other digestive disorders. Papain is used to treat ringworm, remove warts, and heal skin injuries because of its capacity to break down dead tissue without harming living tissue. Bromelain is used in the treatment of cardiovascular disease, decrustation of burns and as an anti-inflammatory agent. Animal-based protein hydrolysis enzymes are applied in the pharmaceutical industry include pepsin, trypsin & chymotrypsin, hyaluronidase, urokinase and collagenase. Pepsin is mainly used to aid protein digestion. Trypsin can be used as a wet or dry dressing as well as an ointment. Hyaluronidase helps drug diffusion when conjugated with other drugs such as antibiotics, adrenalin, heparin, and local anesthesia. Urokinase and collagenase in blood clot removal and skin ulcers.
In the protein hydrolysis enzymes market, “microbial” segment is registering the highest growth during the forecast period
Microbial segment is fastest growing segment as microorganisms are excellent source of enzymes due to their wide biochemical diversity and their susceptibility to genetic manipulation. Moreover, protein hydrolysis enzymes from microorganisms are preferred as they possess the desired characteristics for their applications in baking, brewing, detergents, fermented products, pharmaceuticals, textiles, and leather processing among others. Increasing need for sustainable solutions is driving the demand for microbial enzymes. Microbes have been and still are one of the most significant and beneficial sources of many enzymes. Major markets for these enzymes include North America and Europe. In addition, the demand for microbial enzymes in the Asia Pacific region is also projected to increase rapidly, particularly in China, Japan, and India due to increasing industrialization in the region. Microbial product manufacturing companies includes Novozymes (Denmark), Advanced Enzymes Technologies (India), Aumgene Biosciences (India), Amano Enzyme (India).